Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine testing for diagnosis of unexplained syncope
2004-002262-37Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of adenosine in syncope (5 cohorts), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Sensitivity of the adenosine test for diagnosing conduction and neurally mediated syncope syndromes and Specificity of the adenosine test for diagnosing conduction and neurally mediated syncope syndromes. Started Feb 2005; status: completed.
02
Drugs
adenosine
03
Conditions
syncope
Beyond the preview
Go deeper on 2004-002262-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002262-37.